New pelvic implant aims to help seniors heal faster

NCT ID NCT07530497

Recruiting now Disease control Sponsor: SI-BONE, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study will follow 120 adults aged 60 and older who have a pelvic fracture and are scheduled to receive the iFuse TORQ TNT implant, a screw-like device that stabilizes the pelvis. Researchers will check if the device stays in place, doesn't break, and doesn't require additional surgery. The goal is to see how well this implant works in real-world settings for treating pelvic fractures caused by falls or bone weakness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: iFuse TORQ TNT implant (a metal screw-like device to stabilize pelvic fractures)
What this could lead to: If successful, this could show that the iFuse TORQ TNT implant is a safe and effective option for fixing pelvic fractures in older adults, potentially reducing pain and improving mobility.
What could go wrong: This is an early real-world study with no control group, so results may not prove the implant is better than other treatments. Risks include device breakage, migration, or need for revision surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRACTURE; PELVIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone fracture Fractures, Stress hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FRACTURE; PELVIC FRAGILITY FRACTURE INSUFFICIENCY FRACTURES SACROILIAC JOINT DISRUPTION SACROILIAC JOINT DYSFUNCTION SACROILIAC; FUSION

Contacts and locations

Locations

Orthopaedic Associates of Reading
RECRUITING

Wyomissing, Pennsylvania, 19610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.